Healthcare - Biotechnology - NASDAQ - US
$ 0.5497
-7.16 %
$ 93.6 M
Market Cap
-0.46
P/E
Price Target
Average
127.40%
Revenue Forecast
Estimate
23.74%
EBIT
Estimate
--23.57%
Net Income
Estimate
5.79%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Seres Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for MCRB of $1.25 , with forecasts ranging from a low of $1.25 to a high of $1.25 .
MCRB Lowest Price Target
Wall Street Target
1.25 USD
127.40%
MCRB Average Price Target
Wall Street Target
1.25 USD
127.40%
MCRB Highest Price Target
Wall Street Target
1.25 USD
127.40%
REVENUE FORECAST
Revenue Forecast Chart MCRB
EBIT FORECAST
EBIT Forecast Chart MCRB
NET INCOME FORECAST
Net Income Chart MCRB